Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Clinical trial NCT03389555 · COMPLETED

Trial details

NCT number: NCT03389555
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sepsis Septic Shock Metabolic Disturbance

Start date: 2018-02-09
Primary completion: 2019-11-26
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.